To the Editor: Cystoscopy is considered the gold standard as a diagnostic tool for recurrent urothelial cell carcinomas (UCCs). Unfortunately, this procedure is both invasive and costly. As a noninvasive alternative, various biomarkers have been tested in the urine of patients with bladder cancer (1 ). One of the most promising markers is the presence of telomerase activity (1, 2). Following th...
